Fisher JE et al. |
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9874784
|
Niv H et al. |
Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies. |
1999 |
J. Biol. Chem. |
pmid:9880539
|
Hartmann MA et al. |
Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin. |
2000 |
Biochem. Soc. Trans. |
pmid:11171211
|
Beedle AM and Zamponi GW |
Block of voltage-dependent calcium channels by aliphatic monoamines. |
2000 |
Biophys. J. |
pmid:10866952
|
Mo H et al. |
Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas. |
2000 |
Cancer Lett. |
pmid:10936674
|
Toró A et al. |
Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. |
2000 |
Org. Lett. |
pmid:10964353
|
Yang W et al. |
Protein farnesylation is critical for maintaining normal cell morphology and canavanine resistance in Schizosaccharomyces pombe. |
2000 |
J. Biol. Chem. |
pmid:10617635
|
Hanley K et al. |
Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. |
2000 |
J. Biol. Chem. |
pmid:10753967
|
Bringmann A et al. |
Farnesol modulates membrane currents in human retinal glial cells. |
2000 |
J. Neurosci. Res. |
pmid:11054809
|
Halaschek-Wiener J et al. |
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. |
2000 |
Mol. Med. |
pmid:11055588
|
Xie H et al. |
Synthesis and biological evaluation of the geometric farnesylated analogues of the a-factor mating peptide of Saccharomyces cerevisiae. |
2000 |
J. Org. Chem. |
pmid:11112575
|
Eskens FA et al. |
Farnesyl transferase inhibitors: current developments and future perspectives. |
2000 |
Cancer Treat. Rev. |
pmid:11006134
|
Kloog Y and Cox AD |
RAS inhibitors: potential for cancer therapeutics. |
2000 |
Mol Med Today |
pmid:11006529
|
Hemmerlin A and Bach TJ |
Farnesol-induced cell death and stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in tobacco cv bright yellow-2 cells. |
2000 |
Plant Physiol. |
pmid:10938345
|
Mussoni L et al. |
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. |
2000 |
Thromb. Haemost. |
pmid:10928471
|
Rioja A et al. |
Preferential induction of apoptosis of leukaemic cells by farnesol. |
2000 |
FEBS Lett. |
pmid:10675556
|
Hemmer W et al. |
Axillary dermatitis from farnesol in a deodorant. |
2000 |
Contact Derm. |
pmid:10727172
|
Rosado JA and Sage SO |
Farnesylcysteine analogues inhibit store-regulated Ca2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton. |
2000 |
Biochem. J. |
pmid:10727417
|
Flach J et al. |
The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10733934
|
Nah J et al. |
Partial characterization of farnesyl and geranylgeranyl diphosphatases induced in rice seedlings by UV-C irradiation. |
2001 |
Plant Cell Physiol. |
pmid:11522913
|